Stay updated on Elafibranor in NASH: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.

Latest updates to the Elafibranor in NASH: Efficacy & Safety Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page no longer displays the government funding status notice, and the rest of the study details and location information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedUpdated study locations list with changes to participating sites, including additions and removals. This affects where potential participants can enroll.SummaryDifference0.1%

- Check47 days agoChange DetectedTwo study sites in Santiago de Cali (760032, 760042) were removed and two new sites in Cali (760032, 760042) were added.SummaryDifference0.1%

- Check68 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference1%

- Check76 days agoChange DetectedCore content sections on drug safety and related topics were removed, and a new version tag v3.1.0 was added. This indicates content consolidation and a version upgrade with less emphasis on the previously listed drug-safety topics.SummaryDifference0.2%

Stay in the know with updates to Elafibranor in NASH: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.